Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry L Nadler

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Lipoxygenases and lipid signaling in vascular cells in diabetesRama Natarajan, Jerry L Nadler
Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2004
Lipid inflammatory mediators in diabetic vascular diseaseRama Natarajan, Jerry L Nadler
Metabolism: Clinical and Experimental|March 12, 2004
Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal ratsJohn S Striffler, Jerry L Nadler
Current Diabetes Reports|March 20, 2003
Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetesMilagros G Huerta, Jerry L Nadler
Current Diabetes Reports|June 6, 2007
Inflammatory mechanisms of diabetic complicationsMichael D Williams, Jerry L Nadler
Biochemical Pharmacology|December 14, 2004
Lisofylline: a potential lead for the treatment of diabetesZandong Yang, Meng Chen, Jerry L Nadler
Endocrinology|January 23, 2003
12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cellsJiali Gu, Yeshao Wen, Angeles Mison, et al.
Endocrinology|May 22, 2002
Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolismMeng Chen, Zandong Yang, Runpei Wu, et al.
Critical Care (London, England)|September 15, 2012
Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injuryJan Rossaint, Jerry L Nadler, Klaus Ley, et al.
Plos One|November 12, 2015
Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for β-Cell Dysfunction Induced by Inflammatory CytokinesJessica R Weaver, Jerry L Nadler, David A Taylor-Fishwick
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Lipoxygenases and lipid signaling in vascular cells in diabetesRama Natarajan, Jerry L Nadler
Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2004
Lipid inflammatory mediators in diabetic vascular diseaseRama Natarajan, Jerry L Nadler
Metabolism: Clinical and Experimental|March 12, 2004
Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal ratsJohn S Striffler, Jerry L Nadler
Current Diabetes Reports|March 20, 2003
Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetesMilagros G Huerta, Jerry L Nadler
Current Diabetes Reports|June 6, 2007
Inflammatory mechanisms of diabetic complicationsMichael D Williams, Jerry L Nadler
Biochemical Pharmacology|December 14, 2004
Lisofylline: a potential lead for the treatment of diabetesZandong Yang, Meng Chen, Jerry L Nadler
Endocrinology|January 23, 2003
12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cellsJiali Gu, Yeshao Wen, Angeles Mison, et al.
Endocrinology|May 22, 2002
Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolismMeng Chen, Zandong Yang, Runpei Wu, et al.
Critical Care (London, England)|September 15, 2012
Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injuryJan Rossaint, Jerry L Nadler, Klaus Ley, et al.
Plos One|November 12, 2015
Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for β-Cell Dysfunction Induced by Inflammatory CytokinesJessica R Weaver, Jerry L Nadler, David A Taylor-Fishwick
Pageof 13